StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
INV$5.83+9.47%
Fair $5.83+0.0%

INV

Innventure, Inc.

Financial Services / Asset ManagementNasdaqGM

$5.83

+0.51 (+9.47%)

Fairly Valued+0.0%Fair Value $5.83Fund rank 30/100 · Data gapFallback financials|
SA 33/D
F-Score: 2/9
Low Profitability

Book/ROE base 3Y

n/d

n/d CAGR · P/B n/d

Book/ROE base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 100% · confianza 20%

Book/ROE escenarios

weak_data · book/share n/d · quality 0.0/100

Data gap 30/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 32/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

33/100

D

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); financial Book/ROE targets are disabled until manually verified. ROE is -50.9%, below the 5% threshold
Thesis & Journal · INVLocal privado en este navegador · Innventure, Inc.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$490M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-50.9%

↓

Gross Margin

-815.9%

↓

Debt/Equity

0.06

↓
52-Week Range$6
$2$8

TradingView lightweight chart

INV price, volumen y niveles de valoración

Último $5.835Periodo -41.6%
Fair value: $5.835

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+29.7%

FCF CAGR

—

FCF margin

-3993.2%

FCF / Net income

0.28x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $2.1M · net income $-293.3M · FCF $-82.1M

2022-FY → 2025-FY

Gross margin

-815.9%— pts

Operating margin

-5746.2%-3127.4% pts

Net margin

-14266.4%-10789.0% pts

FCF margin

-3993.2%-2936.9% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$2.1M$2.1M$1.2M$1.1M$942000.00
Net Income$-293.3M$-293.3M$-76.5M$-30.8M$-32.8M
EBITDA$-456.6M$-456.6M$-91.8M$-29.8M$-31.9M
EPS-5.39-5.39-1.80-0.72-0.77
Gross Margin-815.9%-815.9%-271.2%100.0%—
Operating Margin-5746.2%-5746.2%-6212.2%-2119.8%-2618.8%
Net Margin-14266.4%-14266.4%-6268.3%-2761.4%-3477.4%
Balance Sheet
Debt/Equity0.060.060.06—-0.50
Current Ratio1.371.37———
Cash Flow
Free Cash Flow$-82.1M$-82.1M$-48.9M$-20.1M$-9.9M
Returns
ROE-50.9%-50.9%-15.2%—276.5%
Valuation
P/B0.550.551.20——
Growth & Yield
Revenue Growth68.5%68.5%9.2%18.6%—
EPS Growth-198.6%-198.6%-149.8%5.8%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +2.2%

Total return

+2.2%

Start / end P/E

n/dx → n/dx

EPS bridge

-1.80 → -5.39

Residual

+2.2%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+2.2%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.